RE:RE:RE:No wonder they wanted a RS, huge dilution coming this yearOK if you want to get specific, if ALL warrants are exercised the share dilution is 17%, but not accounting for exercise price and assuming all warrants are exercised is a little too opaque for my liking.
The reverse split isn't a factor until it is. Quite a few companies that are financed in early stages by warrants and debentures have literature in their MDA's citing reverse splits of some nature. It gives them more flexibility if needed for future financing. I doubt they do any reverse split, considering share counts of almost every other cannabis company.
But hey, if you guys want to worry about exercising of warrants and debenture conversions, go ahead. Those are short/near term hiccups, once that debt is cancelled (one way or another), what problems do you see Supreme facing?
Interested in how all of you guys would have financed this company (or any mid tier producer)?